Swiss Life Asset Management Ltd
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1637689
Zurich, V8
Position in BMRN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$956,317
+$70,837 QoQ
Shares Held
16,713
+6.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#278
of 561 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss Life Asset Management Ltd holds $122,705,584 across 67 Biotechnology names. BMRN ranks #12 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,614 | $45,507,422 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,220 | $17,596,298 | |
| 3 | INCY |
Incyte Corp
|
104,901 | $11,891,577 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,327 | $8,828,306 | |
| 5 | RPRX |
Royalty Pharma plc
|
136,283 | $7,641,386 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,736 | $3,321,598 | |
| 7 | INSM |
INSMED Inc
|
27,552 | $2,937,594 | |
| 8 | MRNA |
Moderna, Inc.
|
25,088 | $1,756,912 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $956,317 | 16,713 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $885,480 | 15,675 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $762,962 | 12,838 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,098,635 | 20,285 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $4,098,947 | 74,567 | Shares | Sole | 2025-12-02 | |
| 2025-03-31 | $1,165,960 | 16,494 | Shares | Defined | 2025-12-02 | |
| 2024-12-31 | $767,463 | 11,676 | Shares | Sole | 2025-12-09 | |
| 2024-06-30 | $222,126 | 2,698 | Shares | Sole | 2025-12-09 | |
| 2024-03-31 | $314,249 | 3,598 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $457,320 | 4,743 | Shares | Sole | 2025-12-09 | |
| 2023-09-30 | $437,268 | 4,942 | Shares | Defined | 2025-12-09 | |
| 2023-06-30 | $3,449,689 | 39,798 | Shares | Defined | 2025-12-09 | |
| 2023-03-31 | $3,766,591 | 38,735 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $3,734,540 | 36,086 | Shares | Sole | 2025-12-09 | |
| 2022-09-30 | $3,175,653 | 37,462 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $2,960,281 | 35,722 | Shares | Sole | 2025-12-09 | |
| 2022-03-31 | $2,271,288 | 29,459 | Shares | Sole | 2025-12-09 | |
| 2021-12-31 | $2,618,605 | 29,639 | Shares | Sole | 2025-12-29 | |
| 2021-09-30 | $2,290,798 | 29,639 | Shares | Sole | 2025-12-29 | |
| 2021-06-30 | $2,473,078 | 29,639 | Shares | Sole | 2025-12-29 | |
| 2021-03-31 | $2,401,369 | 31,802 | Shares | Sole | 2025-12-29 | |
| 2020-12-31 | $2,842,559 | 32,416 | Shares | Sole | 2025-12-29 | |
| 2020-09-30 | $2,466,209 | 32,416 | Shares | Sole | 2025-12-29 | |
| 2020-06-30 | $3,681,205 | 29,846 | Shares | Sole | 2025-12-29 | |
| 2020-03-31 | $2,521,987 | 29,846 | Shares | Sole | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||